ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02984995
Brief Title: Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation

First Submitted : December 5, 2016
First Submitted that Met QC Criteria : December 5, 2016
First Posted : December 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 2, 2018
Last Update Posted : October 3, 2018